News Announcement

Jenburkt Pharmaceuticals: Reg. 34 (1) Annual Report.

Submission of the Annual Report for the FY 2025-26 containing Audited Standalone Financial Statements Auditors Report and Directors Report and the Notice convening 41st Annual General Meeting of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan